Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00180180

Enrollment

Registered

2005-09-16

Start date

2006-07-31

Completion date

2018-10-31

Last updated

2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Neoplasms

Keywords

head-and-neck cancer, radiation therapy, F-18-FMISO

Brief summary

The purpose of this study is to describe the regional and global tumor hypoxia in head-and-neck cancer during percutaneous radiation therapy

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* histologically confirmed head-and-neck cancer not curable by surgery * Karnofsky \> 70% * tumor volume and localisation allow curative radiotherapy * written consent

Exclusion criteria

* metastases * earlier radiation therapy of head and neck * pregnancy * secondary malignancy excluding dermal carcinoma and Tis-carcinoma of cervix uteri * psychiatric impairment

Countries

Germany

Outcome results